Beam Therapeutics Inc. (BEAM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 2.74B |
| Enterprise Value | 2.74B |
| P/E Ratio | -25.15 |
| PEG Ratio | -0.74 |
| Price/Sales Ratio | 17.71 |
| Price/Book Ratio | 2.76 |
| Enterprise/Revenue | 17.93 |
| Enterprise/EBITDA | -30.94 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.73 |
| Operating Margin | -2.68 |
| Return On Assets | -0.08 |
| Return On Equity | -0.1 |
| Revenue | 139.74M |
| Revenue/Share | 1.4 |
| Gross Profit | 117.45M |
| EBITDA | -13.97M |
| Net Income | -79.99M |
| Diluted EPS | -0.81 |
| Total Cash | 1.04B |
| Total Cash/Share | 9.97 |
| Total Debt | 243.87M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 13 |
| Book Value Per Share | 9.1 |
| 52-Week Change | 16.17 |
| 52-Week High | 38.26 |
| 52-Week Low | 20.23 |
| Moving Average 50 Days | 25.53 |
| Moving Average 200 Days | 27.98 |
| Average Volume | 1.86M |
| Shares Outstanding | 103.29M |
| % Held by Institutions | 105.71 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |